▶ 調査レポート

世界のパーキンソン病治療市場予測（～2024年）：企業別、地域別、種類・用途別
• 英文タイトル：Global Parkinson’s Disease Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024

GlobalInfoResearchが調査・発行した産業分析レポートです。世界のパーキンソン病治療市場予測（～2024年）：企業別、地域別、種類・用途別 / Global Parkinson’s Disease Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024 / B-GIR09F3344資料のイメージです。• レポートコード：B-GIR09F3344
• 出版社/出版日：GlobalInfoResearch / 2019年10月11日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、122ページ
• 納品方法：Eメール
• 産業分類：Medical Care
• 販売価格（消費税別）
  Single User￥515,040 (USD3,480)▷ お問い合わせ
  Multi User￥772,560 (USD5,220)▷ お問い合わせ
  Corporate User￥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
本調査レポートは、パーキンソン病治療の世界市場について調べ、まとめました。種類別セグメントは、経口、経皮、皮下、腸内注入等、用途別セグメントは、病院薬局、小売薬局、オンライン薬局等に区分しました。パーキンソン病治療の世界市場概観、企業動向、企業別パーキンソン病治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・パーキンソン病治療の市場概観
・パーキンソン病治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・パーキンソン病治療の企業別販売動向、市場シェア、市場集中度、競争動向
・パーキンソン病治療の世界市場規模
・パーキンソン病治療の北米市場分析（アメリカ、カナダ、メキシコ等）
・パーキンソン病治療のアメリカ市場規模推移
・パーキンソン病治療のカナダ市場規模推移
・パーキンソン病治療のメキシコ市場規模推移
・パーキンソン病治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・パーキンソン病治療のドイツ市場規模推移
・パーキンソン病治療のイギリス市場規模推移
・パーキンソン病治療のロシア市場規模推移
・パーキンソン病治療のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・パーキンソン病治療の日本市場規模推移
・パーキンソン病治療の中国市場規模推移
・パーキンソン病治療の韓国市場規模推移
・パーキンソン病治療のインド市場規模推移
・パーキンソン病治療の東南アジア市場規模推移
・パーキンソン病治療の南米市場分析（ブラジル、アルゼンチン等）
・パーキンソン病治療の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・パーキンソン病治療の種類別分析/販売量、売上、市場シェア（経口、経皮、皮下、腸内注入）
・パーキンソン病治療の用途別分析/市場規模（病院薬局、小売薬局、オンライン薬局）
・パーキンソン病治療の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・パーキンソン病治療の販売チャネル・代理店・貿易業者・ディーラー分析

Scope of the Report:
The global Parkinson’s Disease Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Parkinson’s Disease Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Parkinson’s Disease Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Parkinson’s Disease Treatment market by product type and applications/end industries.

Market Segment by Companies, this report covers
UCB
AbbVie
Acorda Therapeutics
Roche
Teva
Prothena
Orion Pharmaceuticals
Impax Pharmaceuticals
Voyager Therapeutics
MSD
Sunovion
Intec Pharma
GSK
Acadia
NeuroDerm
Adamas Therapeutics

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Oral
Transdermal
Subcutaneous
Intestinal Infusion

Market Segment by Applications, can be divided into
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

レポート目次

Table of Contents

1 Parkinson’s Disease Treatment Market Overview
1.1 Product Overview and Scope of Parkinson’s Disease Treatment
1.2 Classification of Parkinson’s Disease Treatment by Types
1.2.1 Global Parkinson’s Disease Treatment Revenue Comparison by Types (2019-2024)
1.2.2 Global Parkinson’s Disease Treatment Revenue Market Share by Types in 2018
1.2.3 Oral
1.2.4 Transdermal
1.2.5 Subcutaneous
1.2.6 Intestinal Infusion
1.3 Global Parkinson’s Disease Treatment Market by Application
1.3.1 Global Parkinson’s Disease Treatment Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Global Parkinson’s Disease Treatment Market by Regions
1.4.1 Global Parkinson’s Disease Treatment Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Parkinson’s Disease Treatment Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Parkinson’s Disease Treatment Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Parkinson’s Disease Treatment Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Parkinson’s Disease Treatment Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Parkinson’s Disease Treatment Status and Prospect (2014-2024)
1.5 Global Market Size of Parkinson’s Disease Treatment (2014-2024)
2 Company Profiles
2.1 UCB
2.1.1 Business Overview
2.1.2 Parkinson’s Disease Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 UCB Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.2 AbbVie
2.2.1 Business Overview
2.2.2 Parkinson’s Disease Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 AbbVie Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.3 Acorda Therapeutics
2.3.1 Business Overview
2.3.2 Parkinson’s Disease Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Acorda Therapeutics Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.4 Roche
2.4.1 Business Overview
2.4.2 Parkinson’s Disease Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Roche Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.5 Teva
2.5.1 Business Overview
2.5.2 Parkinson’s Disease Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Teva Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.6 Prothena
2.6.1 Business Overview
2.6.2 Parkinson’s Disease Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Prothena Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.7 Orion Pharmaceuticals
2.7.1 Business Overview
2.7.2 Parkinson’s Disease Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Orion Pharmaceuticals Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.8 Impax Pharmaceuticals
2.8.1 Business Overview
2.8.2 Parkinson’s Disease Treatment Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Impax Pharmaceuticals Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.9 Voyager Therapeutics
2.9.1 Business Overview
2.9.2 Parkinson’s Disease Treatment Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Voyager Therapeutics Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.10 MSD
2.10.1 Business Overview
2.10.2 Parkinson’s Disease Treatment Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 MSD Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.11 Sunovion
2.11.1 Business Overview
2.11.2 Parkinson’s Disease Treatment Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Sunovion Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.12 Intec Pharma
2.12.1 Business Overview
2.12.2 Parkinson’s Disease Treatment Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Intec Pharma Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.13 GSK
2.13.1 Business Overview
2.13.2 Parkinson’s Disease Treatment Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 GSK Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.14 Acadia
2.14.1 Business Overview
2.14.2 Parkinson’s Disease Treatment Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Acadia Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.15 NeuroDerm
2.15.1 Business Overview
2.15.2 Parkinson’s Disease Treatment Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 NeuroDerm Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.16 Adamas Therapeutics
2.16.1 Business Overview
2.16.2 Parkinson’s Disease Treatment Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Adamas Therapeutics Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
3 Global Parkinson’s Disease Treatment Market Competition, by Players
3.1 Global Parkinson’s Disease Treatment Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Parkinson’s Disease Treatment Players Market Share
3.2.2 Top 10 Parkinson’s Disease Treatment Players Market Share
3.3 Market Competition Trend
4 Global Parkinson’s Disease Treatment Market Size by Regions
4.1 Global Parkinson’s Disease Treatment Revenue and Market Share by Regions
4.2 North America Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
4.3 Europe Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
4.5 South America Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
5 North America Parkinson’s Disease Treatment Revenue by Countries
5.1 North America Parkinson’s Disease Treatment Revenue by Countries (2014-2019)
5.2 USA Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
5.3 Canada Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
5.4 Mexico Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
6 Europe Parkinson’s Disease Treatment Revenue by Countries
6.1 Europe Parkinson’s Disease Treatment Revenue by Countries (2014-2019)
6.2 Germany Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
6.3 UK Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
6.4 France Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
6.5 Russia Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
6.6 Italy Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Parkinson’s Disease Treatment Revenue by Countries
7.1 Asia-Pacific Parkinson’s Disease Treatment Revenue by Countries (2014-2019)
7.2 China Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
7.3 Japan Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
7.4 Korea Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
7.5 India Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
8 South America Parkinson’s Disease Treatment Revenue by Countries
8.1 South America Parkinson’s Disease Treatment Revenue by Countries (2014-2019)
8.2 Brazil Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
8.3 Argentina Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
8.4 Colombia Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Parkinson’s Disease Treatment by Countries
9.1 Middle East and Africa Parkinson’s Disease Treatment Revenue by Countries (2014-2019)
9.2 Saudi Arabia Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
9.3 UAE Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
9.4 Egypt Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
9.5 Nigeria Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
9.6 South Africa Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
10 Global Parkinson’s Disease Treatment Market Segment by Type
10.1 Global Parkinson’s Disease Treatment Revenue and Market Share by Type (2014-2019)
10.2 Global Parkinson’s Disease Treatment Market Forecast by Type (2019-2024)
10.3 Oral Revenue Growth Rate (2014-2024)
10.4 Transdermal Revenue Growth Rate (2014-2024)
10.5 Subcutaneous Revenue Growth Rate (2014-2024)
10.6 Intestinal Infusion Revenue Growth Rate (2014-2024)
11 Global Parkinson’s Disease Treatment Market Segment by Application
11.1 Global Parkinson’s Disease Treatment Revenue Market Share by Application (2014-2019)
11.2 Parkinson’s Disease Treatment Market Forecast by Application (2019-2024)
11.3 Hospital Pharmacy Revenue Growth (2014-2019)
11.4 Retail Pharmacy Revenue Growth (2014-2019)
11.5 Online Pharmacy Revenue Growth (2014-2019)
12 Global Parkinson’s Disease Treatment Market Size Forecast (2019-2024)
12.1 Global Parkinson’s Disease Treatment Market Size Forecast (2019-2024)
12.2 Global Parkinson’s Disease Treatment Market Forecast by Regions (2019-2024)
12.3 North America Parkinson’s Disease Treatment Revenue Market Forecast (2019-2024)
12.4 Europe Parkinson’s Disease Treatment Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Parkinson’s Disease Treatment Revenue Market Forecast (2019-2024)
12.6 South America Parkinson’s Disease Treatment Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Parkinson’s Disease Treatment Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Parkinson’s Disease Treatment Picture
Table Product Specifications of Parkinson’s Disease Treatment
Table Global Parkinson’s Disease Treatment and Revenue (Million USD) Market Split by Product Type
Figure Global Parkinson’s Disease Treatment Revenue Market Share by Types in 2018
Figure Oral Picture
Figure Transdermal Picture
Figure Subcutaneous Picture
Figure Intestinal Infusion Picture
Table Global Parkinson’s Disease Treatment Revenue (Million USD) by Application (2014-2024)
Figure Parkinson’s Disease Treatment Revenue Market Share by Applications in 2018
Figure Hospital Pharmacy Picture
Figure Retail Pharmacy Picture
Figure Online Pharmacy Picture
Table Global Market Parkinson’s Disease Treatment Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Parkinson’s Disease Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Parkinson’s Disease Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Parkinson’s Disease Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Parkinson’s Disease Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Parkinson’s Disease Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Parkinson’s Disease Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Table UCB Basic Information, Manufacturing Base and Competitors
Table UCB Parkinson’s Disease Treatment Type and Applications
Table UCB Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table AbbVie Basic Information, Manufacturing Base and Competitors
Table AbbVie Parkinson’s Disease Treatment Type and Applications
Table AbbVie Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Acorda Therapeutics Basic Information, Manufacturing Base and Competitors
Table Acorda Therapeutics Parkinson’s Disease Treatment Type and Applications
Table Acorda Therapeutics Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Parkinson’s Disease Treatment Type and Applications
Table Roche Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Teva Basic Information, Manufacturing Base and Competitors
Table Teva Parkinson’s Disease Treatment Type and Applications
Table Teva Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Prothena Basic Information, Manufacturing Base and Competitors
Table Prothena Parkinson’s Disease Treatment Type and Applications
Table Prothena Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Orion Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Orion Pharmaceuticals Parkinson’s Disease Treatment Type and Applications
Table Orion Pharmaceuticals Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Impax Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Impax Pharmaceuticals Parkinson’s Disease Treatment Type and Applications
Table Impax Pharmaceuticals Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Voyager Therapeutics Basic Information, Manufacturing Base and Competitors
Table Voyager Therapeutics Parkinson’s Disease Treatment Type and Applications
Table Voyager Therapeutics Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table MSD Basic Information, Manufacturing Base and Competitors
Table MSD Parkinson’s Disease Treatment Type and Applications
Table MSD Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Sunovion Basic Information, Manufacturing Base and Competitors
Table Sunovion Parkinson’s Disease Treatment Type and Applications
Table Sunovion Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Intec Pharma Basic Information, Manufacturing Base and Competitors
Table Intec Pharma Parkinson’s Disease Treatment Type and Applications
Table Intec Pharma Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table GSK Basic Information, Manufacturing Base and Competitors
Table GSK Parkinson’s Disease Treatment Type and Applications
Table GSK Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Acadia Basic Information, Manufacturing Base and Competitors
Table Acadia Parkinson’s Disease Treatment Type and Applications
Table Acadia Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table NeuroDerm Basic Information, Manufacturing Base and Competitors
Table NeuroDerm Parkinson’s Disease Treatment Type and Applications
Table NeuroDerm Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Adamas Therapeutics Basic Information, Manufacturing Base and Competitors
Table Adamas Therapeutics Parkinson’s Disease Treatment Type and Applications
Table Adamas Therapeutics Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Global Parkinson’s Disease Treatment Revenue (Million USD) by Players (2014-2019)
Table Global Parkinson’s Disease Treatment Revenue Share by Players (2014-2019)
Figure Global Parkinson’s Disease Treatment Revenue Share by Players in 2017
Figure Global Parkinson’s Disease Treatment Revenue Share by Players in 2018
Figure Global Top 5 Players Parkinson’s Disease Treatment Revenue Market Share in 2018
Figure Global Top 10 Players Parkinson’s Disease Treatment Revenue Market Share in 2018
Figure Global Parkinson’s Disease Treatment Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Parkinson’s Disease Treatment Revenue (Million USD) by Regions (2014-2019)
Table Global Parkinson’s Disease Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Parkinson’s Disease Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Parkinson’s Disease Treatment Revenue Market Share by Regions in 2018
Figure North America Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Europe Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
Figure South America Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
Table North America Parkinson’s Disease Treatment Revenue by Countries (2014-2019)
Table North America Parkinson’s Disease Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Parkinson’s Disease Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Parkinson’s Disease Treatment Revenue Market Share by Countries in 2018
Figure USA Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Canada Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Mexico Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
Table Europe Parkinson’s Disease Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Europe Parkinson’s Disease Treatment Revenue Market Share by Countries (2014-2019)
Figure Europe Parkinson’s Disease Treatment Revenue Market Share by Countries in 2018
Figure Germany Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
Figure UK Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
Figure France Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Russia Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Italy Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Parkinson’s Disease Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Parkinson’s Disease Treatment Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Parkinson’s Disease Treatment Revenue Market Share by Countries in 2018
Figure China Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Japan Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Korea Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
Figure India Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
Table South America Parkinson’s Disease Treatment Revenue by Countries (2014-2019)
Table South America Parkinson’s Disease Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Parkinson’s Disease Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Parkinson’s Disease Treatment Revenue Market Share by Countries in 2018
Figure Brazil Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Argentina Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Colombia Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Parkinson’s Disease Treatment Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Parkinson’s Disease Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Parkinson’s Disease Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Parkinson’s Disease Treatment Revenue Market Share by Countries in 2018
Figure Saudi Arabia Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
Figure UAE Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Egypt Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Nigeria Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
Figure South Africa Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
Table Global Parkinson’s Disease Treatment Revenue (Million USD) by Type (2014-2019)
Table Global Parkinson’s Disease Treatment Revenue Share by Type (2014-2019)
Figure Global Parkinson’s Disease Treatment Revenue Share by Type (2014-2019)
Figure Global Parkinson’s Disease Treatment Revenue Share by Type in 2018
Table Global Parkinson’s Disease Treatment Revenue Forecast by Type (2019-2024)
Figure Global Parkinson’s Disease Treatment Market Share Forecast by Type (2019-2024)
Figure Global Oral Revenue Growth Rate (2014-2019)
Figure Global Transdermal Revenue Growth Rate (2014-2019)
Figure Global Subcutaneous Revenue Growth Rate (2014-2019)
Figure Global Intestinal Infusion Revenue Growth Rate (2014-2019)
Table Global Parkinson’s Disease Treatment Revenue by Application (2014-2019)
Table Global Parkinson’s Disease Treatment Revenue Share by Application (2014-2019)
Figure Global Parkinson’s Disease Treatment Revenue Share by Application (2014-2019)
Figure Global Parkinson’s Disease Treatment Revenue Share by Application in 2018
Table Global Parkinson’s Disease Treatment Revenue Forecast by Application (2019-2024)
Figure Global Parkinson’s Disease Treatment Market Share Forecast by Application (2019-2024)
Figure Global Hospital Pharmacy Revenue Growth Rate (2014-2019)
Figure Global Retail Pharmacy Revenue Growth Rate (2014-2019)
Figure Global Online Pharmacy Revenue Growth Rate (2014-2019)
Figure Global Parkinson’s Disease Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Parkinson’s Disease Treatment Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Parkinson’s Disease Treatment Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Parkinson’s Disease Treatment Revenue Market Forecast (2019-2024)
Figure Europe Parkinson’s Disease Treatment Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Parkinson’s Disease Treatment Revenue Market Forecast (2019-2024)
Figure South America Parkinson’s Disease Treatment Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Parkinson’s Disease Treatment Revenue Market Forecast (2019-2024)

以下、関連資料のご紹介
  • 世界のレフサム病治療市場予測（～2024年）
    Global Refsum Disease Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
    B-GIR09D4255 2019年9月18日 119Pages
    本調査レポートは、レフサム病治療の世界市場について調べ、まとめました。種類別セグメントは、手術療法、薬物療法等、用途別セグメントは、病院、診療所、その他等に区分しました。レフサム病治療の世界市場概観、企業動向、企業別レフサム病治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域...
  • 世界のアジソン病治療市場予測（～2024年）
    Global Addison's Disease Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
    B-GIR09D3757 2019年9月18日 119Pages
    本調査レポートは、アジソン病治療の世界市場について調べ、まとめました。種類別セグメントは、経口コルチコステロイド、コルチコステロイド注射等、用途別セグメントは、病院、診療所、その他等に区分しました。アジソン病治療の世界市場概観、企業動向、企業別アジソン病治療シェア、市場規模推移、市場規模予測（201...
  • 世界のバッテン病治療市場予測（～2024年）
    Global Batten Disease Treatment Market 2019 by Manufacturers, Countries, Type and Application, Forecast to 2024
    B-GIR09D0515 2019年9月4日 120Pages
    本調査レポートは、バッテン病治療の世界市場について調べ、まとめました。種類別セグメントは、作業療法、理学療法等、用途別セグメントは、幼児NCL、後期幼児NCL、少年NCL、成人NCL等に区分しました。バッテン病治療の世界市場概観、メーカー動向、メーカー別バッテン病治療シェア、市場規模推移、市場規模予...
  • 世界の消失性骨疾患治療市場予測（～2024年）
    Global Vanishing Bone Disease Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
    B-GIR09D4352 2019年9月18日 122Pages
    本調査レポートは、消失性骨疾患治療の世界市場について調べ、まとめました。種類別セグメントは、医学療法、放射線療法等、用途別セグメントは、病院、診療所、その他等に区分しました。消失性骨疾患治療の世界市場概観、企業動向、企業別消失性骨疾患治療シェア、市場規模推移、市場規模予測（2019年-2024年）、...
  • 世界の珍炎症性疾患市場予測（～2024年）
    Global Rare Inflammatory Disease Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
    B-GIR09D4244 2019年9月18日 118Pages
    本調査レポートは、珍炎症性疾患の世界市場について調べ、まとめました。種類別セグメントは、注射剤、経口剤、その他等、用途別セグメントは、病院薬局、小売薬局、オンライン薬局等に区分しました。珍炎症性疾患の世界市場概観、企業動向、企業別珍炎症性疾患シェア、市場規模推移、市場規模予測（2019年-2024年...
  • 世界の腎疾患治療市場予測（～2024年）
    Global Renal Disease Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
    B-GIR09D4259 2019年9月18日 118Pages
    本調査レポートは、腎疾患治療の世界市場について調べ、まとめました。種類別セグメントは、急性腎障害、慢性腎疾患、その他等、用途別セグメントは、病院、診療所、研究センター、その他等に区分しました。腎疾患治療の世界市場概観、企業動向、企業別腎疾患治療シェア、市場規模推移、市場規模予測（2019年-2024...
  • 髄膜炎菌性疾患治療市場：世界及び中国市場分析・予測（～2024年）
    Meningococcal Disease Treatment Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    C9OT4183 2019年10月8日 141Pages
    「髄膜炎菌性疾患治療市場：世界及び中国市場分析・予測（～2024年）」は、世界及び中国における髄膜炎菌性疾患治療市場について調査・分析したレポートで、髄膜炎菌性疾患治療の世界市場動向、市場規模、主要企業情報などが含まれています。髄膜炎菌性疾患治療のタイプ別には、抗生物質、ワクチンに分けて分析し、地域...
  • レイノー病治療市場：世界及び中国市場分析・予測（～2024年）
    Raynauds Disease Treatment Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    C9OT9038 2019年10月1日 144Pages
    「レイノー病治療市場：世界及び中国市場分析・予測（～2024年）」は、世界及び中国におけるレイノー病治療市場について調査・分析したレポートで、レイノー病治療の世界市場動向、市場規模、主要企業情報などが含まれています。
    ・レイノー病治療産業の概要
    ・レイノー病治療の製造技術分析...
  • ベーチェット病治療市場：世界及び中国市場分析・予測（～2024年）
    Behcet Disease Treatment Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    C9OT0880 2019年10月1日 146Pages
    「ベーチェット病治療市場：世界及び中国市場分析・予測（～2024年）」は、世界及び中国におけるベーチェット病治療市場について調査・分析したレポートで、ベーチェット病治療の世界市場動向、市場規模、主要企業情報などが含まれています。ベーチェット病治療のタイプ別には、アダリムマブ・バイオシミラー、アプレミ...
  • 鎌状赤血球症治療市場：世界及び中国市場分析・予測（～2024年）
    Sickle Cell Disease Treatment Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    C9OT9148 2019年10月1日 144Pages
    「鎌状赤血球症治療市場：世界及び中国市場分析・予測（～2024年）」は、世界及び中国における鎌状赤血球症治療市場について調査・分析したレポートで、鎌状赤血球症治療の世界市場動向、市場規模、主要企業情報などが含まれています。
    ・鎌状赤血球症治療産業の概要
    ・鎌状赤血球症治療の製...
  • 世界のアジソン病治療市場予測（～2024年）世界のアジソン病治療市場予測（～2024年） Addison's disease, also known as primary adrenal insufficiency and hypocortisolism, is a long-term endocrine disorder in which the adrenal glands do not produce enough steroid hormones. Symptoms generally come on slowly and may include abdominal pain, weakness, and weight loss. Darkening of the skin…
  • 世界のレフサム病治療市場予測（～2024年）世界のレフサム病治療市場予測（～2024年） Refsum disease, also known as classic or adult Refsum disease, heredopathia atactica polyneuritiformis, phytanic acid oxidase deficiency and phytanic acid storage disease, is an autosomal recessive neurological disease that results in the over-accumulation of phytanic acid in cells and tissues. Scop…
  • 世界のバッテン病治療市場予測（～2024年）世界のバッテン病治療市場予測（～2024年） Batten disease is inherited disorder of the nervous system which begins in childhood.It is also called as neuronal ceroid lipofuscinoses (or NCLs). Batten Disease Treatment is the treatment of this type of disease. Scope of the Report: The global Batten Disease Treatment market is valued at xx milli…
  • 世界の珍炎症性疾患市場予測（～2024年）世界の珍炎症性疾患市場予測（～2024年） Scope of the Report: The global Rare Inflammatory Disease Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially…
  • 世界の消失性骨疾患治療市場予測（～2024年）世界の消失性骨疾患治療市場予測（～2024年） Vanishing bone disease or Gorham-stout syndrome is a rare skeletal disease characterized by progressive osteolysis and the proliferation of lymphatic vessels within the bone which leads to the destruction and absorption of bone. Additionally, the bones affected by the disease are more prone to osteo…